The evolution of the pharmaceutical-biotechnology industry

References

• Baum , J. A. , Calabrese , T. and Silverman , B. S. 2000 . Don't do it alone: Alliance network composition and startups' performance in Canadian biotechnology . Strategic Management Journal , 21 ( 3 ) : 267 – 294 .
   Web of Science ®Google Scholar
• Big trouble for big pharmaceutical . December 4 2003 . The Economist December 4 , 55 – 56 .
   Google Scholar
• Christensen , C. 1997 . The innovator's dilemma , Boston : Harvard Business School Press .
   Google Scholar
• Climbing the helical staircase . March 27 2003 . The Economist March 27 , 3 – 7 .
   Google Scholar
• Couzin , J. 2001 . Biotechnology: Desperate no more . The Industry Standard , June 27 Available from http://www.thestandard.com/biotech-desperate-no-more (accessed December 2007)
   Google Scholar
• Davies , K. 2001 . Cracking the genome: Inside the race to unlock human DNA , New York : The Free Press .
   Google Scholar
• EU, European Commission . 2002 . Enterprise Directorate General, 2002 European Innovation Scoreboard, Tech. Paper No.7, Biotechnology Innovation Scoreboard
   Google Scholar
• Goldman Sachs . 2005 . “ Strategic alliances in biotechnology ” . In Goldman Sachs Global Equity Research , New York : Goldman Sachs .
   Google Scholar
• Gottinger , H. W. 2003 . The economies of network industries , London : Routledge .
   Google Scholar
• Hensley , S. 2004 . Human genome's chief is to retire . The Wall Street Journal , March 25
   PubMedGoogle Scholar
• Lerner , J. and Merges , R. P. 1998 . The control of technology alliances: An empirical analysis of the biotechnology industry . The Journal of Industrial Economics , 46 ( 2 ) : 125 – 156 .
   Web of Science ®Google Scholar
• Lichtenberg , F. R. 2006 . “ Pharmaceutical innovation as a process of creative destruction ” . In Knowledge accumulation and industry evolution: The case of pharmaceutical-biotechnology , Edited by: Mazzucato , M. and Dosi , G. 21 – 72 . Cambridge : Cambridge University Press .
   Google Scholar
• Mazzucato M. Dosi G. Knowledge accumulation and industry evolution: The case of Pharma-Biotech Cambridge University Press Cambridge 2006
   Google Scholar
• Nightingale , P. and Mahdi , S. 2006 . “ The evolution of pharmaceutical innovation ” . In Knowledge accumulation and industry evolution: The case of pharmaceutical-biotechnology , Edited by: Mazzucato , M. and Dosi , G. 73 – 111 . Cambridge : Cambridge University Press .
   Google Scholar
• Pisano , G. P. R&D performance, collaborative arrangements, and the market for know-how: A test of the ‘lemons’ hypothesis in biotechnology. Working Paper . Harvard Business School .
   Google Scholar
• Powell , W. W. , Koput , K. W. and Smith-Doerr , L. 1996 . Interorganizational collaboration and the locus of innovation: Networks of learning in biotechnology . Administrative Science Quarterly , 41 : 116 – 145 .
   Web of Science ®Google Scholar
• Robbins-Roth , C. 2000 . From alchemy to IPO: The business of biotechnology , Cambridge , MA : Perseus .
   Google Scholar
• Schering-Plough . 2001 . Annual report 2001 , Kenilworth , NJ : Schering-Plough Corporation .
   Google Scholar
• Stipp , D. 2001 . Bill Haseltine . Fortune , June 25 : 101 – 112 .
   Google Scholar
• Structural genomics: Strategic thinking . June 9 2001 . The Economist June 9 , 82 – 83 .
   Google Scholar
• Tanouye , E. and Langreth , R. 1977 . Time's up: With patents expiring on big prescriptions, drug industry quakes . The Wall Street Journal , August 12
   Google Scholar
• Temin , P. 1980 . Taking your medicine, drug regulation in the United States , Cambridge , MA : Harvard University Press .
   Google Scholar
• Vitrup , D. , Melamud , E. , Moult , J. and Sander , C. 2001 . Completeness in structural genomics . Nature Structural Biology , 8 ( 6 ) : 559 – 563 .
   PubMedGoogle Scholar